• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用非甾体抗炎药与头颈癌风险:前瞻性队列研究的剂量反应荟萃分析

Nonsteroidal anti-inflammatory drugs using and risk of head and neck cancer: a dose-response meta analysis of prospective cohort studies.

作者信息

Shi Jun, Leng Weidong, Zhao Lunhua, Xu Chenli, Wang Jue, Chen Xiaoli, Wang Yu, Peng Xingchun

机构信息

Department of Stomatology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, China.

School of Basic Medical Sciences, Hubei University of Medicine, Shiyan, Hubei, 442000, China.

出版信息

Oncotarget. 2017 Oct 5;8(58):99066-99074. doi: 10.18632/oncotarget.21524. eCollection 2017 Nov 17.

DOI:10.18632/oncotarget.21524
PMID:29228752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5716792/
Abstract

Conflicting results identifying the relationship between nonsteroidal anti-inflammatory drugs using and head and neck cancer risk. Therefore, we performed this meta-analysis to clarify and quantitative assessed the relationship between nonsteroidal anti-inflammatory drugs using and head and neck cancer risk. Up to March 2017, 11 original publications were included in this meta-analysis. Our results showed statistically significant association between nonsteroidal anti-inflammatory drugs using and head and neck cancer risk reduction. Subgroups analysis indicated that Aspirin, COX 2 inhibitors, Ibuprofen and Other NSAIDs were associated with a significantly risk reduction of head and neck cancer. Furthermore, nonsteroidal anti-inflammatory drugs using was associated with a significantly lower risk of oral and oropharynx cancer, larynx cancer and hypopharynx cancer. In addition, increasing nonsteroidal anti-inflammatory drugs using (per 2 prescriptions/week increment) was associated with a 4% reduction in head and neck cancer risk, 5% reduction of aspirin using and 6% reduction of other nonsteroidal anti-inflammatory drugs using. Considering these promising results, increasing nonsteroidal anti-inflammatory drugs using might provide health benefits. More studies and large sample size are warranted to validate this association.

摘要

关于非甾体抗炎药的使用与头颈癌风险之间的关系,研究结果存在冲突。因此,我们进行了这项荟萃分析,以阐明并定量评估非甾体抗炎药的使用与头颈癌风险之间的关系。截至2017年3月,共有11篇原始文献纳入了这项荟萃分析。我们的结果显示,非甾体抗炎药的使用与头颈癌风险降低之间存在统计学上的显著关联。亚组分析表明,阿司匹林、COX-2抑制剂、布洛芬和其他非甾体抗炎药与头颈癌风险的显著降低相关。此外,使用非甾体抗炎药与口腔和口咽癌、喉癌和下咽癌的风险显著降低相关。另外,非甾体抗炎药使用量增加(每增加2张处方/周)与头颈癌风险降低4%、阿司匹林使用量降低5%以及其他非甾体抗炎药使用量降低6%相关。鉴于这些有前景的结果,增加非甾体抗炎药的使用可能对健康有益。需要更多研究和大样本量来验证这种关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01b/5716792/07c0384180d6/oncotarget-08-99066-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01b/5716792/afa83b348fc6/oncotarget-08-99066-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01b/5716792/d61a57326dc1/oncotarget-08-99066-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01b/5716792/472405b5137e/oncotarget-08-99066-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01b/5716792/07c0384180d6/oncotarget-08-99066-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01b/5716792/afa83b348fc6/oncotarget-08-99066-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01b/5716792/d61a57326dc1/oncotarget-08-99066-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01b/5716792/472405b5137e/oncotarget-08-99066-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01b/5716792/07c0384180d6/oncotarget-08-99066-g004.jpg

相似文献

1
Nonsteroidal anti-inflammatory drugs using and risk of head and neck cancer: a dose-response meta analysis of prospective cohort studies.使用非甾体抗炎药与头颈癌风险:前瞻性队列研究的剂量反应荟萃分析
Oncotarget. 2017 Oct 5;8(58):99066-99074. doi: 10.18632/oncotarget.21524. eCollection 2017 Nov 17.
2
Association of nonsteroidal anti-inflammatory drugs and aspirin use and the risk of head and neck cancers: a meta-analysis of observational studies.非甾体抗炎药和阿司匹林的使用与头颈癌风险的关联:观察性研究的荟萃分析
Oncotarget. 2016 Oct 4;7(40):65196-65207. doi: 10.18632/oncotarget.11239.
3
Association between nonsteroidal anti-inflammatory drugs use and risk of central nervous system tumors: a dose-response meta analysis.非甾体抗炎药的使用与中枢神经系统肿瘤风险之间的关联:一项剂量反应荟萃分析。
Oncotarget. 2017 Oct 11;8(60):102486-102498. doi: 10.18632/oncotarget.21829. eCollection 2017 Nov 24.
4
Tooth loss and cancer risk: a dose-response meta analysis of prospective cohort studies.牙齿缺失与癌症风险:前瞻性队列研究的剂量反应荟萃分析
Oncotarget. 2017 Dec 16;9(19):15090-15100. doi: 10.18632/oncotarget.23850. eCollection 2018 Mar 13.
5
Nonsteroidal anti-inflammatory drugs and esophageal inflammation - Barrett's esophagus - adenocarcinoma sequence: a meta-analysis.非甾体抗炎药与食管炎症-巴雷特食管-腺癌序列:一项荟萃分析
Dis Esophagus. 2011 Jul;24(5):318-24. doi: 10.1111/j.1442-2050.2010.01153.x. Epub 2010 Dec 17.
6
Nonsteroidal anti-inflammatory drugs exposure and the central nervous system.非甾体抗炎药暴露与中枢神经系统
Handb Clin Neurol. 2014;119:577-84. doi: 10.1016/B978-0-7020-4086-3.00038-2.
7
8
Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.长期使用阿司匹林和非甾体抗炎药与结直肠癌风险
JAMA. 2005 Aug 24;294(8):914-23. doi: 10.1001/jama.294.8.914.
9
Non-steroidal anti-inflammatory drugs and the risk of head and neck cancer: A case-control analysis.非甾体抗炎药与头颈部癌症风险:病例对照分析。
Int J Cancer. 2015 Nov 15;137(10):2424-31. doi: 10.1002/ijc.29601. Epub 2015 Jul 15.
10
Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.乳腺癌与非甾体抗炎药的使用:一项荟萃分析。
J Natl Cancer Inst. 2008 Oct 15;100(20):1439-47. doi: 10.1093/jnci/djn324. Epub 2008 Oct 7.

引用本文的文献

1
Gemcitabine and Flurbiprofen Enhance Cytotoxic Effects on Cancer Cell Lines Mediated by Mesenchymal Stem Cells.吉西他滨和氟比洛芬增强间充质干细胞介导的对癌细胞系的细胞毒性作用。
Int J Mol Sci. 2025 Jun 27;26(13):6212. doi: 10.3390/ijms26136212.
2
Acetylsalicylic Acid and Head and Neck Cancer: Risk, Five-Year Survival, and Recurrence in over 11,000,000 Patients-A Retrospective Case-Control Study.乙酰水杨酸与头颈癌:1100多万患者的风险、五年生存率及复发情况——一项回顾性病例对照研究
Cancers (Basel). 2025 Jun 20;17(13):2065. doi: 10.3390/cancers17132065.
3
NSAID-encapsulated nanoparticles as a targeted therapeutic platform for modulating chronic inflammation and inhibiting cancer progression: a review.

本文引用的文献

1
Aspirin and other non-steroidal anti-inflammatory drug prescriptions and survival after the diagnosis of head and neck and oesophageal cancer.阿司匹林及其他非甾体抗炎药处方与头颈癌和食管癌诊断后的生存率
Cancer Epidemiol. 2015 Dec;39(6):1015-22. doi: 10.1016/j.canep.2015.10.030. Epub 2015 Nov 18.
2
Non-steroidal anti-inflammatory drugs and the risk of head and neck cancer: A case-control analysis.非甾体抗炎药与头颈部癌症风险:病例对照分析。
Int J Cancer. 2015 Nov 15;137(10):2424-31. doi: 10.1002/ijc.29601. Epub 2015 Jul 15.
3
Regular aspirin use and nasopharyngeal cancer risk: A case-control study in Italy.
非甾体抗炎药包裹的纳米颗粒作为调节慢性炎症和抑制癌症进展的靶向治疗平台:综述
Inflammopharmacology. 2025 Apr 26. doi: 10.1007/s10787-025-01760-8.
4
Microbes, macrophages, and melanin: a unifying theory of disease as exemplified by cancer.微生物、巨噬细胞与黑色素:以癌症为例的疾病统一理论
Front Immunol. 2025 Feb 6;15:1493978. doi: 10.3389/fimmu.2024.1493978. eCollection 2024.
5
Significantly Positive Impact of Nonsteroidal Anti-inflammatory Drugs Combined With Osmoprotectant (Osmolytes) in Cancer Treatment.非甾体抗炎药联合渗透保护剂(渗透溶质)在癌症治疗中的显著积极影响。
Cureus. 2024 Jun 30;16(6):e63529. doi: 10.7759/cureus.63529. eCollection 2024 Jun.
6
Chemoprevention of Head and Neck Cancer: A Review of Current Approaches and Future Perspectives.头颈部癌症的化学预防:当前方法和未来展望的综述。
Cancer Prev Res (Phila). 2024 Oct 1;17(10):443-455. doi: 10.1158/1940-6207.CAPR-24-0093.
7
The relationship between nonsteroidal anti-inflammatory drugs and cancer incidence: An umbrella review.非甾体抗炎药与癌症发病率之间的关系:一项汇总分析。
Heliyon. 2024 Jan 12;10(2):e23203. doi: 10.1016/j.heliyon.2023.e23203. eCollection 2024 Jan 30.
8
The molecular characteristics of colorectal cancer: Impact of Ibuprofen and hyperthermia.结直肠癌的分子特征:布洛芬与热疗的影响
Mol Biol Res Commun. 2023;12(1):17-25. doi: 10.22099/mbrc.2023.45296.1802.
9
Ketorolac modulates Rac-1/HIF-1α/DDX3/β-catenin signalling via a tumor suppressor prostate apoptosis response-4 (Par-4) in renal cell carcinoma.酮咯酸通过肿瘤抑制因子前列腺凋亡反应蛋白 4(Par-4)调节肾细胞癌中的 Rac-1/HIF-1α/DDX3/β-catenin 信号通路。
Sci Rep. 2023 Apr 6;13(1):5659. doi: 10.1038/s41598-023-32627-z.
10
Gene Expression of the D-Series Resolvin Pathway Predicts Activation of Anti-Tumor Immunity and Clinical Outcomes in Head and Neck Cancer.D 系列 resolvin 通路的基因表达可预测头颈部癌症中的抗肿瘤免疫激活和临床结局。
Int J Mol Sci. 2022 Jun 9;23(12):6473. doi: 10.3390/ijms23126473.
常规使用阿司匹林与鼻咽癌风险:意大利的一项病例对照研究。
Cancer Epidemiol. 2015 Aug;39(4):545-7. doi: 10.1016/j.canep.2015.04.012. Epub 2015 May 8.
4
Fruits and vegetables intake and risk of bladder cancer: a PRISMA-compliant systematic review and dose-response meta-analysis of prospective cohort studies.水果和蔬菜摄入量与膀胱癌风险:一项符合PRISMA标准的前瞻性队列研究的系统评价和剂量反应荟萃分析
Medicine (Baltimore). 2015 May;94(17):e759. doi: 10.1097/MD.0000000000000759.
5
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
6
Aspirin and non-steroidal anti-inflammatory drug use and the risk of upper aerodigestive tract cancer.阿司匹林及非甾体抗炎药的使用与上消化道癌症风险
Br J Cancer. 2014 Oct 28;111(9):1852-9. doi: 10.1038/bjc.2014.473. Epub 2014 Sep 11.
7
Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer.非甾体抗炎药和阿司匹林的使用与头颈部癌症的风险。
Br J Cancer. 2013 Mar 19;108(5):1178-81. doi: 10.1038/bjc.2013.73. Epub 2013 Feb 28.
8
Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software.线性和非线性剂量-反应关系的荟萃分析:实例、近似值的评估和软件。
Am J Epidemiol. 2012 Jan 1;175(1):66-73. doi: 10.1093/aje/kwr265. Epub 2011 Dec 1.
9
Aspirin use and breast cancer risk: a meta-analysis.阿司匹林的使用与乳腺癌风险:一项荟萃分析。
Breast Cancer Res Treat. 2012 Jan;131(2):581-7. doi: 10.1007/s10549-011-1747-0. Epub 2011 Sep 4.
10
Role of medical history and medication use in the aetiology of upper aerodigestive tract cancers in Europe: the ARCAGE study.欧洲上呼吸道和消化道癌症病因中的医学史和药物使用情况的作用:ARCAGE 研究。
Ann Oncol. 2012 Apr;23(4):1053-60. doi: 10.1093/annonc/mdr335. Epub 2011 Aug 9.